局限性肾癌治疗决策影响因素:混合方法系统综述
该混合方法系统综述检索了2004年至2020年间的PubMed、Embase和Cochrane数据库,最终纳入42篇文章,旨在理解局限性肾癌治疗决策过程中的障碍与促进因素。关键主题被归纳为肿瘤特征、决策者相关标准和背景因素三个领域,主要促进因素包括诊断时大小、年龄、合并症等,主要障碍包括种族、性别、患者焦虑、对诊疗选择信心低、手术费用和实践模式。未来干预措施应考虑这些因素以改善患者体验。
要点
- 局限性肾癌治疗决策受肿瘤特征、决策者因素和背景因素三方面影响。
- 促进决策的因素包括肿瘤大小、年龄、合并症、BMI、肾周评分系统等。
- 障碍包括种族、性别、患者焦虑、对诊疗选择信心低、费用和实践模式。
核心结论
- 未来改善局限性肾癌决策的干预措施应考虑已识别的障碍与促进因素。
研究设计与样本
- 混合方法系统综述,检索PubMed、Embase和Cochrane Central数据库2004年1月1日至2020年4月23日文献。
- 共识别553条唯一引文,排除511条后纳入42篇文章进行综合。
主要发现
- 关键主题归纳为三个领域:肾癌特定特征、决策者相关标准和背景因素。
- 主要促进因素包括诊断时大小、年龄、合并症、体重指数、性别、肾周评分系统、活检、社会经济状态、癌症家族史、诊断年份、地理区域和实践模式。
- 主要障碍包括种族、性别、患者焦虑、对诊断和治疗选择信心低、手术费用和实践模式。
临床怎么用
- 临床决策时应综合考虑肿瘤特征、患者因素和背景因素,关注已识别的障碍与促进因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: With a growing number of treatment options for localized kidney cancer, patients and health care professionals have both the opportunity and the burden of selecting the most suitable management option. This mixed method systematic review aims to understand the barriers and facilitators of the treatment decision making process in localized kidney cancer. MATERIALS AND METHODS: We searched PubMed®, Embase® and Cochrane Central databases between January 1, 2004 and April 23, 2020 using the Joanna Briggs Manual for Evidence Synthesis and the Preferred Reporting Items for Systematic Review and Meta-analysis statement. We identified 553 unique citations; of these, 511 were excluded resulting in 42 articles included for synthesis. The Purpose, Respondents, Explanation, Findings and Significance and the Strengthening the Reporting of Observational Studies in Epidemiology checklist was applied. RESULTS: The key themes describing barriers and facilitators to treatment decision making were identified and categorized into 3 domains: 1) kidney cancer specific characteristics, 2) decision maker related criteria and 3) contextual factors. The main facilitators identified within these domains were size at diagnosis, age, comorbidities, body mass index, gender, nephrometry scoring systems, biopsy, socioeconomic status, family history of cancer, year of diagnosis, geographic region and practice pattern. The key barriers were race, gender, patient anxiety, low confidence in diagnostic and treatment options, cost of procedure, and practice patterns. CONCLUSIONS: Future interventions designed to improve the decision making process for localized kidney cancer should consider these barriers and facilitators to ensure a better patient experience.
引用
- Beyer K, Barod R, Fox L, et al. The Current Evidence for Factors that Influence Treatment Decision Making in Localized Kidney Cancer: A Mixed Methods Systematic Review. J Urol. 2021. PMID: 34111958. doi:10.1097/JU.0000000000001901
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。